| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |